ERBB2 and gastric cancer: 5, 5, 3, and 2 mutations of KRAS, PIK3CA, ERBB2 and CTNNB1 were observed in 4, 4, 3, and 2 gastric cancers, respectively (5, 3, 3, and 2 hotspot mutations, respectively) (Tables 1 and 2).